JPMA Embarking on Creation of One-Stop Platform for Rare Disease Trial Info

Masahiro Ishida, Leader, Rare and Intractable Disease Taskforce, JPMA The Japan Pharmaceutical Manufacturers Association (JPMA) has set out to build a platform that gives patients one-stop access to clinical trial information for rare and intractable diseases. The trade group hopes...read more